Background: excess weight is a risk factor for numerous co-morbidities that predominantly occur in later life. This study's purpose was to analyse the association between excess weight and health service use/costs in the older population in Germany. Methods: this cross-sectional analysis used data of n = 3,108 individuals aged 58-82 from a population-based prospective cohort study. Body mass index (BMI) and waist-to-height ratio (WHtR) were calculated based on clinical examinations. Health service use was measured by a questionnaire for a 3-month period. Corresponding costs were calculated applying a societal perspective. Results: 21.8% of the sample were normal weight, 43.0% overweight, 25.5% obese class 1 and 9.6% obese class ≥2 according to BMI. In 42.6%, WHtR was ≥0.6. For normal weight, overweight, obese class 1 and obese class ≥2 individuals, mean costs (3-month period) of outpatient care were 384€, 435€, 475€ and 525€ (P < 0.001), mean costs of inpatient care were 284€, 408€, 333 € and 652€ (P = 0.070) and mean total costs 716€, 891€, 852€ and 1,244€ (P = 0.013). For individuals with WHtR <0.6 versus ≥0.6, outpatient costs were 401€ versus 499€ (P < 0.001), inpatient costs 315€ versus 480€ (P = 0.016) and total costs 755€ versus 1,041€ (P < 0.001). Multiple regression analyses controlling for sociodemographic variables showed a significant effect of obesity on costs of outpatient care (class 1: +72€; class ≥2: +153€) and total costs (class ≥2: +361€) while the effect of overweight was not significant. WHtR ≥0.6 significantly increased outpatient costs by +79€ and total costs by +189€. Conclusions: excess weight is associated with increased service use and cost in elderly individuals, in particular in obese class ≥2 individuals.
Introduction
Obesity substantially increased in recent decades and is now among the leading risk factors for non-communicable diseases in the developed world [1, 2] . Characterised by an excess of body fat, obesity is a chronic condition with a complex genetic-environmental aetiology, resulting in multiple organspecific pathological consequences [3] . Health risks increase with excess fat, leading to substantial morbidity and disability, impaired quality of life and increased mortality [3] [4] [5] .
As ageing and obesity independently contribute to healthcare utilisation and spending [17, 18] , an increasingly obese older population will likely pose financial pressures for health care and social security systems. The purpose of this study was to analyse the association between excess weight and health service use and costs in a representative sample of the (currently) older population in Germany.
Methods Sample
This cross-sectional analysis used data from the 8-year follow-up contact of a large population-based prospective cohort study (ESTHER study), conducted in the German federal state of Saarland. Detailed information about the study design and the participants of the ESTHER study has been reported elsewhere [19, 20] . In brief, baseline recruitment of the ESTHER cohort was conducted between July 2000 and December 2002 and included 9,949 participants aged 50-74. Standardised postal questionnaires on sociodemographic, medical and lifestyle factors were completed at baseline and three follow-ups (2, 5 and 8 years) . At the 8-year follow-up, supplemental information on morbidity was collected by questionnaires sent to the study participants' general practitioners (GPs). By or during the time of the 8-year follow-up, 1,033 individuals had deceased and 1,210 had discontinued further active participation, 253 of them due to health reasons. In the 8-year follow-up, information from the participants' or GP's questionnaire were available for 7,012 study participants (80.9% response rate among survivors still mentally and physically able to respond). Information from both questionnaires was collected for 5,057 of the participants. In addition, all participants were asked to take part in a 3-h geriatric assessment conducted at their homes by trained study physicians, which included the measurement of body height, waist circumference (WC) and weight as well as an assessment of health service use to be used for the present analysis. Three thousand one hundred and twenty-four individuals participated in this assessment between July 2008 and December 2010. Of these participants, 16 individuals with underweight (body mass index (BMI) <18.5 kg/m 2 ) were excluded, resulting in the final sample of 3,108 individuals used for the analyses presented here.
Data

Sociodemographic data
Sociodemographic data (age, gender, marital status, years of schooling, health insurance status and income) were obtained from the postal questionnaire. Income is reported as the square root equivalence scale (SRES) that divides the household income by the square root of the household size [21] . Since the income was assessed per month, the amount of the SRES was multiplied by 3 to obtain the income for a 3-month period (see below).
Measures of overweight and obesity
As part of the geriatric assessment, participants' height, weight and WC were measured by the study physicians at the participants' homes. BMI was calculated and categorised as normal weight (18.5 ≤ BMI < 25), overweight (25 ≤ BMI < 30), obesity class 1 (30 ≤ BMI < 35) and obesity class ≥2 (BMI ≥ 35) according to WHO recommendations [22] . Sixteen individuals with underweight (BMI <18.5 kg/m 2 ) were excluded as mentioned above. As a measure of abdominal obesity, waist-to-height-ratio (WHtR) was calculated which in a recent meta-analysis has been shown to be better than BMI and WC in predicting cardiometabolic outcomes [8] . WHtR was categorised as <0.6 versus ≥0.6, since the threshold value WHtR ≥0.6 has been proposed for 'Take Action' [23] . In addition, the threshold WHtR ≥0.5 ('Consider Action' [23] ) was used for sensitivity analysis.
Morbidity
The Cumulative Illness Rating Scale for Geriatrics (CIRS-G) [24] , a modified version of the Cumulative Illness Rating Scale for older adults [25] , was completed by the participants' GPs to quantify morbidity. On the CIRS-G, 13 categories referring to clinically relevant physiological organ systems and 1 category referring to psychiatric illness are rated on a five-point severity scale ranging from 0 (no problem) to 4 (extremely severe). A total score can be constructed from the sum of each of the 14 single categories, which theoretically ranges from 0 to 56 [26] . In addition, the Mini-Mental Status Examination (MMSE [27] ) was used to assess cognitive impairment.
Health service use
Health service use was assessed through an interview conducted by the study physicians at the participants' homes. The interview was based on a shortened version of a questionnaire that was developed by our working group and used in previous studies [28, 29] . The questionnaire is available from the authors upon request. It covers inpatient treatment in general hospitals, specialised psychiatric and neurological hospitals or rehabilitation clinics; outpatient physician treatment by GPs, specialists and outpatient clinics; other outpatient treatment (e.g. physiotherapy or occupational therapy); medical supplies and dental prostheses; nursing home care; and professional community nursing care and informal care. Assessment was retrospective for a period of 3 months for all resources and services. To minimise recall bias, the questionnaire contains lists of common health services and goods used in old age. Pharmaceuticals were recorded during home visits by the study doctors by means of a barcode reader.
Healthcare costs
The cost categories analysed in this study are direct costs of illness, arising from the use of resources. By recording all used resources, regardless of whether they were covered by health or nursing care insurance or paid for out-of-pocket, a societal perspective was adopted in this analysis. Costs were calculated from resource use as recorded in the questionnaire by means of unit costs: days in hospital were monetarily valued by national average costs per day and type of hospital; outpatient contacts by average costs per contact by type of provider; quantities of medical supplies by average reimbursement rates; pharmaceuticals by market prices; days in nursing homes by average costs per day by type and level of dependency; hours of professional community nursing care by hourly gross wage rate plus non-wage labour costs in the nursing sector; hours of informal care by the replacement cost approach, i.e. it was assumed that the same amount of care by professional nursing services would have had to be paid for in the absence of an informal caregiver [30] . Accordingly, hours of informal care were valued using the same hourly wage rate as for professional care. A detailed description of the costing approach and the sources of unit costs has been presented elsewhere [31] .
Costs were calculated in euros at 2009 price levels. Unit costs that were unavailable at year 2009 values were inflated or deflated to year 2009 price levels by means of the consumer price index [32] .
For statistical analysis, we categorised cost data as follows: (i) costs of inpatient care comprising inpatient treatment in general hospitals, specialised psychiatric and neurological hospitals or rehabilitation hospitals; (ii) costs of outpatient care comprising outpatient physician treatment, other outpatient treatment, medical supplies and dental prostheses as well as pharmaceuticals; (iii) costs of nursing care comprising nursing home care, professional community nursing care and informal care.
Statistical analysis
To test differences in proportions, the χ 2 test was used. To test differences in means, Student's t-test or ANOVA was used. Multiple ordinary least squares (OLS) regression analysis with bootstrapped standard errors (4,000 replications) was used to assess the associations of co-variates with healthcare costs. Bootstrapped standard errors were used in regression models due to the fact that resource use and cost data tend to be highly skewed. The level of significance was set at α = 0.05. All statistical analyses were performed using STATA Release 12 (Stata Corp., College Station, TX, USA).
Missing values in the resource-use questionnaire were set at zero, resulting in a conservative estimation of the healthcare service use and costs. Proportions of missing values in all other variables were below 1.5%, except for income (13.0%) and CIRS-G (16.9%, because of unavailability of GP questionnaires). The CIRS-G was only used for sample description.
Ethics
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Results
Sociodemographic characteristics and excess weight
Of the 3,108 respondents, 52.5% were female and 72.0% were married ( Table 1 ). The mean age was 69.6 years. Two-thirds (66.2%) reported <10 years of schooling and 92.2% were covered by statutory health insurance. The mean SRES income for 3 months was 4,303€, and the mean score of the CIRS-G was 6.9. The mean MMSE score was 28.3, with only 1.7% of participants scoring <25, indicating that cognitive impairment was very rare.
21.8% of the sample had normal weight (18.5 ≤ BMI < 25), 43.0% had overweight (25 ≤ BMI < 30), 25.5% were obese class 1 (30 ≤ BMI < 35) and 9.6% were obese class ≥2 (BMI ≥35). In 42.6% of the sample, WHtR was ≥0.6. BMI and WHtR were significantly associated with gender, years of schooling, income, type of health insurance and morbidity measured by the CIRS-G. 
Health service use
During the 3 months preceding the interview, almost all respondents (98.0%) had used outpatient care, with outpatient physician services (95.3%) and pharmaceuticals (85.5%) being used most frequently (Table 2 ). 8.7% had used inpatient care and only 2.4% nursing care, with informal nursing care more frequently used than formal nursing care. BMI and WHtR showed a significant association with use of outpatient physician services, pharmaceuticals and medical supplies: While among normal weight respondents, physician services, pharmaceuticals and medical supplies were used by 93.1, 78.1 and 15.3%, the corresponding proportions of those with obesity class ≥2 were 98.7, 96.3 and 28.1%. WHtR also showed a significant association with use of nursing care (1.9 versus 3.1%).
Health service costs
Mean total costs for the 3-month period amounted to 877€ per person ( Table 2) . Costs of outpatient care (443€) made up more than half of total costs, with costs of outpatient physician services (174€) and costs of pharmaceuticals (170 €) contributing almost equally to costs of outpatient care. Mean costs of inpatient care amounted to 385€, and costs of nursing care were 49€.
BMI was significantly associated with costs of outpatient care and total costs: for normal weight, overweight, obese class 1 and obese class ≥2 individuals, mean costs of outpatient care were 384€, 435€, 475€ and 525€, and mean total costs were 716€, 891€, 852€ and 1,244€. For individuals with WHtR <0.6 versus ≥0.6, outpatient costs were 401€ versus 499€ (P < 0.001), inpatient costs were 315€ versus 480€ (P = 0.016) and total costs were 755€ versus 1,041€ (P < 0.001). Costs of nursing care did not differ significantly between groups.
Multiple regression analyses controlling for age, gender, marital status, education, income and health insurance showed a significant association of obesity defined by BMI with costs of outpatient care (obesity class 1: +72€; class ≥2: +153€) and total costs (class ≥2: +361€). Overweight was not significantly associated with costs (Table 3) . WHtR ≥0.6 significantly increased outpatient costs by +79€ and total costs by +189€. With values between 0.4 and 1.4%, the R²s were rather low.
Sensitivity analysis
In 88.4% of the sample, WHtR was ≥0.5. Compared with WHtR <0.5, WHtR ≥0.5 was associated with significantly increased outpatient costs (368€ versus 452€; P = 0.006), inpatient costs (246€ versus 403€; P = 0.022) and total costs (635€ versus 909€; P<0.001). However, in multiple regression analyses, WHtR ≥0.5 was not significantly associated with increased costs in any of the sectors analysed, and R²s tended to be lower than for the regression models using the threshold WHtR ≥0.6. OLS regression with bootstrapped standard errors (SE) based on 4,000 replications, n = 2,642 due to missing values. *P < 0.05. **P < 0.01. ***P < 0.001; significant (P < 0.05) results are printed bold.
Discussion
In our sample of the German older population, excess weight was associated with significantly increased service use and cost, with obese class ≥2 individuals showing strongly increased costs, in particular for pharmaceuticals: compared with normal weight individuals, costs of pharmaceuticals were more than doubled, and total costs increased by 74% in obesity class ≥2 individuals. In individuals with WHtR ≥0.6, total costs were increased by 38% compared with those with WHtR <0.6, largely due to significantly increased costs of inpatient care and pharmaceuticals (both +52%). After controlling for sociodemographic variables in multiple regression analyses, obese class ≥2 individuals and those with WHtR ≥0.6 still showed significantly increased outpatient costs and total costs compared with normal weight individuals and those with WHtR <0.6; increased inpatient costs did not reach the level of significance, possibly due to the small proportion of users within the 3-month period. The magnitude of the cost-increasing effect of obesity class ≥2 (compared with normal weight) was equal to the effect of 13 years of age. The cost-increasing effect of WHtR ≥0.6 (compared with WHtR <0.6) corresponded to the effect of 8 years of age. These findings are in general comparable to those from the international literature [17] . Very few authors specifically investigated service use and costs in older adults with excess weight, however. Available studies from the USA consistently found significantly increased costs for older adults with overweight and obesity, particularly in outpatient care, albeit the magnitude of excess costs being different between studies [33] [34] [35] . For example, prescription spending by obese class 1 communitydwelling Medicare beneficiaries was found to be increased by 35% compared with normal weight beneficiaries [36] ; in our study, the corresponding increase was 52%. For Germany, empirical evidence on the impact of excess weight on healthcare utilisation and healthcare costs is generally scarce [37] [38] [39] , with no studies investigating the relationship within older adults.
Comparing our results with a study conducted in a sample (n = 942) of the general population aged 25-74 in the south of Germany in the year 2000 indicates that the relative increase of healthcare costs associated with excess weight seems to be smaller than in the (younger) general population. The authors reported a threefold increase of annual costs in obese class ≥2 individuals (2,572€) compared with normal weight individuals (848€) [37] . While in our sample, the corresponding relative increase was only 74%, the absolute difference was similar (+2,112€ extrapolated to annual costs). The reason for the relative increase being smaller is that healthcare costs in normal weight older adults were much higher than those reported for the younger normal weight population.
Interestingly, overweight (and in part obesity class 1) defined by BMI was not associated with significantly increased healthcare costs in multiple regression analyses. BMI categories have been criticised for overestimating the health risks of excess weight in older adults [5, 40] , as various epidemiological studies found a beneficial or neutral effect of overweight and obesity on mortality and disability [5, 40] .
While one reason for this so-called obesity paradox may be due to fact that older adults with normal body weight comprise a mix of those who have (always) been lean and those who have lost weight due to chronic illness, age-related changes in body composition may also contribute to inappropriateness of BMI categories [3, 5] . We therefore also used WHtR as a measure of abdominal obesity, which had been shown to be better than BMI in predicting adverse outcomes [8] . In our regression analyses, dichotomous WHtR (threshold 0.6) explained the same amount of variance in costs as the four categories of BMI and was significantly associated with inpatient costs while an association was not detected with BMI. WHtR ≥0.5 was less strongly associated with costs than WHtR ≥0.6.
The ESTHER study is a representative sample of the German older population [19, 20] , and the prevalence of overweight and obesity was almost identical to what has been reported in a German population survey [7] . Furthermore, we observed that the baseline BMI of participants in our analysed sample from the 8-year follow-up was almost identical with the baseline BMI of those who were not included due to non-response at the 8-year follow-up or death, indicating a representative sample at the 8-year follow-up with respect to the BMI of older German adults [41] . Yet, the number of users of nursing care in the 8-year follow-up of the ESTHER study was low, indicating a potential underrepresentation of frail people who may have more need for healthcare services. As obesity may contribute to increased healthcare service use in frail people, the cost-increasing effect of obesity may be underestimated in our study, in particular for nursing costs, which were not significantly increased. Furthermore, as most healthcare costs occur in a short time period prior to death, costs may be underestimated in our cross-sectional analysis.
In our study, we collected comprehensive self-reported data on health service utilisation from a societal perspective, because no routine database covering all these service categories exists in Germany. The period of retrospective data collection was restricted to 3 months according to the recommendations by Johnston et al. [42] who conducted a comprehensive review on cost assessments alongside clinical trials and found that recall bias can be minimised if the recall period is no longer than 3 months. Yet, despite the short recall period, service use and costs may still be underestimated due to recall problems. Furthermore, the short data collection period of 3 months possibly increased the variance of calculated healthcare costs, which may be a reason for the variance explained by the models being small.
As duration of obesity was not assessed in our study, we could not distinguish whether obesity in old age or surviving with obesity from earlier ages drives the costs. While prevention of obesity earlier in life is considered beneficial and likely to be cost-effective [43] , studies on the effect of voluntary weight loss in the elderly are scare and suggest that exercise and moderate calorie restriction are useful not only for reducing weight but also for managing chronic conditions associated with obesity [5] . In particular, programs improving physical activity tend to be cost-effective [44] .
Conclusions
In conclusion, we found excess weight to be associated with increased service use and cost in older adults, in particular in obese class ≥2 individuals. As prevalence rates of excess weight are higher in the older population compared with younger age groups, population ageing can be expected to substantially increase healthcare cost attributable to excess weight.
Key points
• Excess weight is associated with increased health service use and costs in older adults.
• Dichotomous WHtR explains a similar amount of variance in costs as BMI classes.
• Relative increase in costs associated with excess weight seems to be smaller than in younger populations.
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